Skip to main content

Specialty drugs: Vital for health, but extremely pricey

RC

By

Last updated November 6, 20241 min read
Specialty drugs: Vital for health, but extremely pricey

Do you know what the current factors are that affect specialty pharmaceutical trends? It’s important knowledge to have since it can help your company develop a plan for what benefit they’ll offer as new drugs get FDA approval. 

“We see in the market that 1% to 2% of prescriptions are for specialty drugs, yet this often accounts for greater than 50% of pharmacy spending,” said Katie Asch, senior director, U.S. consulting pharmacy practice lead, Willis Towers Watson. “It is imperative to design a benefit that provides judicious access to these important treatments.”

Specialty drugs are used to treat complex conditions. They’re pricey because they cost more to develop, produce and administer, and often require special handling.

How to keep costs down for firm, staff

There are ways you can manage specialty drugs: financially and clinically.

Some of the things that fall into financial management include:

  • discounts negotiated by firms for individual payers or groups of payers in a purchasing coalition
  • preferred drug lists that include the best value meds and remove comparable higher-cost ones
  • maximizing copay coupons from manufacturers to cover drug costs -spreading the risk of high-cost therapies across many payers, and
  • designing a plan that only allows member’s actual out-of-pocket cost to apply toward deductible and out-of-pocket maximum accumulations.

As for clinical management, the thing that fall under it include:

  • making sure employees receive rare disease or cancer treatment from a center of excellence
  • utilization management (prior authorization, quantity limits and step therapy criteria), and
  • specialized care/case management for rare and specialty conditions

For more info on this complex topic, click here.

Filed underHealth Care
Share

Further Reading

  • Managing Healthcare Costs Without Hurting Employees: HR’s 2027 Challenge

    Open enrollment may feel far away. It isn’t. Summer is when benefits planning for 2027 starts taking shape. With health benefit costs continuing to outpace wages and inflation, employers that start planning now have more flexibility to control healthcare costs. A Familiar Cost-Control Pattern In April and May, Mercer surveyed 604 U.S.-based organizations and found […]

  • How to Make HR-PEO Partnerships Succeed

    Economic uncertainty and rising healthcare costs are now the top concerns for business leaders, according to a 2026 survey from the National Association of Professional Employer Organizations (NAPEO). As those pressures increase, more companies are expressing interest in PEOs to stabilize costs and offload administrative risk. In fact, 87% of non-PEO users say they’re considering […]

  • California’s PBM Law May Become the Blueprint for Employer Oversight

    Employers are about to get more visibility and control over how pharmacy benefits are managed. The new California PBM law, Senate Bill 41, requires full rebate pass-through, prohibits spread pricing and imposes fiduciary duties for pharmacy benefit managers. Although SB 41 applies to PBMs operating in California, national vendors that serve California clients are likely […]